Table 2.
Clinical characteristics of the study cohort
| HS (n = 97) | MCD (n = 223) | LEAT (n = 154) | |
|---|---|---|---|
| Sex | |||
| ȃMale | 46 (47.4%) | 107 (48%) | 92 (59.7%) |
| ȃFemale | 51 (52.6%) | 116 (52%) | 62 (40.3%) |
| Age of onset (years) | |||
| ȃAverage | 13.73 ± 13.25 | 6.32 ± 8.61 | 13.17 ± 12.98 |
| ȃMedian [IQR] | 9.5 [2, 22] | 3 [0.5, 9.25] | 8.75 [4.25, 18] |
| Age at surgery (years) | |||
| ȃAverage ± SD | 39.13 ± 14.15 | 18.5 ± 14.65 | 21.8 ± 16.09 |
| ȃMedian [IQR] | 40 [27, 48] | 17.86 [5, 28] | 17 [9, 31.75] |
| Duration of epilepsy (years) | |||
| ȃAverage ± SD | 25.81 ± 15.26 | 12.23 ± 10.89 | 8.49 ± 9.57 |
| ȃMedian [IQR] | 23.75 [12.75, 36.5] | 10 [3.5, 17.2] | 5 [2, 11] |
| Lateralization | |||
| ȃRight | 45 (52.3%) | 132 (61.1%) | 83 (54.6%) |
| ȃLeft | 41 (47.7%) | 83 (38.4%) | 69 (45.4%) |
| ȃBoth | 0 | 1 (0.5%) | 0 |
| Localization | |||
| ȃTemporal | 97 (100%) | 48 (21.8%) | 114 (74.5%) |
| ȃȃRight | 45 | 28 | 63 |
| ȃȃLeft | 41 | 18 | 50 |
| ȃȃNot specified | 11 | 2 | 1 |
| ȃFrontal | 0 | 96 (43.6%) | 17 (11.1%) |
| ȃȃRight | 0 | 60 | 8 |
| ȃȃLeft | 0 | 35 | 9 |
| ȃȃNot specified | 0 | 1 | 0 |
| ȃParietal | 0 | 11 (5%) | 8 (5.2%) |
| ȃȃRight | 0 | 5 | 5 |
| ȃȃLeft | 0 | 5 | 3 |
| ȃȃNot specified | 0 | 1 | 0 |
| ȃOccipital | 0 | 6 (2.7%) | 3 (2%) |
| ȃȃRight | 0 | 5 | 1 |
| ȃȃLeft | 0 | 1 | 2 |
| ȃMultiple Lobes | 0 | 59 (26.8%) | 11 (7.2%) |
| ȃȃRight | 0 | 34 | 6 |
| ȃȃLeft | 0 | 24 | 5 |
| ȃȃBoth | 0 | 1 | 0 |
| Follow-up time (months) | |||
| ȃAverage ± SD | 31.88 ± 29.4 | 37.71 ± 34.37 | 27.2 ± 19.28 |
| Surgical outcome at last follow-up | |||
| ȃEngel I | 47 (81%) | 120 (63.8%) | 104 (82.5%) |
| ȃȃEngel II | 9 (15.5%) | 20 (10.6%) | 12 (9.5%) |
| ȃȃEngel III-IV | 2 (3.5%) | 48 (25.6%) | 10 (8%) |
IQR = Interquartile range, SD = standard deviation.